DEFENSIVE DRIVING CLASS
6 HOUR COURSE
$17 or $15 with A&M I.D.
Wednesday, April 13 (6-9 pm)
Thursday, April 14 (6-9 pm)
Saturday, April 23
(8:30-11:30 am & 12:30-3:30 pm)
TICKET DISMISSAL - INSURANCE DISCOUNT
MSC UNIVERSITY PLUS 845-1631
Page 10
The Battalion
Thursday, ApriP.ffii
On the go!
WILEY
L E C T U RE
SERIES
Memorial Student (Center'" ^
April 8, 1994, 8:00 p.m. /
Rudder Auditorium
Texas A&M University
N ^ /
X,
Mr. Les Aspin
Former U.S. Secretary of
N Defense
Mr. William F.
Buckley. Jr.
Moderator
Some say\the U.S. is no longer in a position to be
the world's policeman. President Clinton has
attempted to redefine U.S. involvement in the
international community. Kirkpatrick and Aspin
will exatnine both sides of this controversial issue.
Tickets available at the MSC Box Office, oir"call 845-1234.
Juror skips trial for work,
faces $5,000 fine, jail time
Thursday
The Associated Press
Rad
listei
apai
bun
Jennie Mayer/77;<■ Battalion
David Conley, a visitor to the A&M campus,
practices in Research Park on Wednesday.
FORT WORTH — A Chico man says he
was putting his family first when he de
cided to show up for the first day of a
new job rather than jury duty.
Now, he faces a possible $5,000 fine
and six months in federal prison for con
tempt of court.
Brian Clampitt, 23, was selected last
week to hear a drug trial in the court
room of U.S. District Judge Terry Means.
On Thursday, the jury began its delib
erations and then recessed for a long East
er weekend.
But Monday morning, Clampitt did not
return to jury duty. Instead he went to
work.
Clampitt said he felt he would not be
hired if he did not show up for his first
day of work at Jim’s Oilfield Service.
He said bills were stacking up at home
and that the new job would help his wife,
a waitress, and their 2-year-old daughter.
He said he finally decided, “You have to
put your family first.”
A woman who identified herself as
Clampitt’s wife called the U.S. District
Clerk’s Office and said Clampitt was sick
and unable to appear for further jury duty,
federal officials said.
The clerk was told Clampitt was so ill
The Asso
pFORT
.,tion say:
listener;
bidden i
in shaml
I An ai
lountry
based ii
that the family was going to ukei
phone receiver off the hook.
The . judge became suspicious andk
his staff to start making calls. Clamf
was finally tracked down at his new jolt h >
“(Means) just told me I’d betterr.t;| ; J- 31156
to Fort Worth pretty quickly,” Clajiipi:^” rar ^ a
said. “I even got a speeding ticket te I
down there.”
Clampitt joined the rest of the juj
Monday. After four hours of deliberatio
jurors found the three defendants gui
of drug-related charges.
Means called Clampitt to the bencM
ter dismissing the other jurors.
“He just told me that the choice Inn
was a very serious mistake,’’ Clampittst;
Clampitt is scheduled to appear be
the judge next Monday.
He said he has mixed emotions al
what his punishment should be.
“1 think it would be about rightl
them to put me in jail, since I didn’tsb
up in court and it could have meantle
ting drug dealers walk the streets,
Clampitt said.
But he said people get probation for cl
sorts of serious crimes. ^ ,,,
It 1
‘You I
tie abor
.. libraries
dollars 1
tivate i
brary,”
[ The
than 8
brought
clay, rip
and the
floor, s
arsha
“Heck, here they want to put mein
for trying to support my family,” he i|
the Fort Worth Star-Telegram.
Heliskiers risk danger as part of thrill
The Associated Press
RENO, Nev. — They ski moun-
taintops so.remote that they need a
helicopter to get there. They shun
groomed slopes for virgin powder,
crowds for thrills and scenery.
When the day ends, the only tracks
on the mountain will be the miles
of lines they have left behind.
For heliskiers, it’s the ultimate
adventure. Some end up paying
the ultimate price.
The sport is expensive. Like
mountain climbing or whitewater
rafting, death is n£ver far away.
On Sunday, Walt Disney Co.
President Frank Wells was return
ing from a heliskiing trip in the
Ruby Mountains 25 miles south
west of Elko, Nev., when the chop
per crashed into a steep canyon.
Wells, a fellow passenger and
the pilot were killed. Two others
were seriously injured.
Two days earlier, model Christie
Brinkley and four others were in
jured when their chopper went
down after a trip near Telluride,
Colo. They were stranded for about
six hours.
A copter crash in January 1993
killed four people, including Brent
Patterson, who owned Diamond
Peak Heli-Ski Adventures near Og
den, Utah.
“There’s inherent hazards in
this activity. This is an adventure
sport,’’ said Greg Smith, owner
and founder of Wasatch Powerbird
Guides in Snowbird, Utah.
“It’s a thrilling activity, but
there’s more risk involved in doing
it than sitting aMiome reading
about it. This is a very uncon
trolled environment.’^
About 62,000 heliski trips are
made each year in North America.
They can cost as little as $450 for a
day or more than $ 1,650 for a
three-day trip.
“It’s the difference between
gourmet dining and fast food,”
said Ross McGaw, marketing direc
tor at Mountain Helisports near
Whistler, British Columbia. “It is a
rush being around the helicopter
lifting you up to run after run of
untracked beautiful powder snow.
It’s something you can never get
tired of.”
The inviting powder also can be
a peril. A skier can unknowingly
plunge into a drift-filled bowl and
suffocate. Mountain storms can
move in with vicious winds, blind
ing snow and bitter cold. Most of
the skiing is in avalanche zones.
Three years ago, an avalanche
swept nine heliskiers to their
deaths in the Purcell Mountains,
some 400 miles east of Whistler.
Trained guides pick thesafesti
ing areas, away from knows
avalanche danger. They watch I
weather and screen skiers for abifc
“Route finding, terrain seleo
tion, good guiding can redoti
the avalanche danger,” Smi
said. “But this is not an exactsc
ence. That danger cannot be 10
tally eliminated. ’
Skiers are placed in approprir
ability groups, he said, and sora
below intermediate level an
turned back.
“We’ve picked up people iniks
morning reeking of marijuana
we have to say no,” McGaw said
“We’ve got to protect theraselve
and ourselves, and other peopi:
because people are stupid some
times.”
Smith and 'McGa'xV say death
and injuries among helisidbY/zr
no higher than on the ski slopes
in and
[the she!
And
'climb
on eacb
pie in t
Liste
that the
10,00
the DJ
“W
we ne
said,
for the
pened.
He
dio sta
facials
“It
inspir;
he doe
40 pec
leave,’
No
made.
severa
return
As
brary
. up ab
floor,
I COLLEGE
PREGNANCIES
PRESSURES
*■
. * ■
OPTIONS
COMMUNITY RESPONSIBILITY
A panel discussion featuring representatives from the
Department of Psychology and the Student Counseling
Center on dealing with the stresses associated with
unexpected college pregnancies.
Harrington 108
Thursday, April 7
7:00 p.m.
presented by
DepoProvera®
Contraceptive Injection
(sterile medroxyprogesterone acetate suspension, USP)
WHAT IS DEPO-PROVERA CONTRACEPTIVE INJECTION?
DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intra
muscular injection (a shot) in the buttock or upper arm once every 3 months. To continue
your contraceptive protection, you must return for your next injection promptly at the end of
3 months. DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to
(but not the same as) the natural hormone progesterone, which is produced by your ovaries
during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your
egg cells from ripening. If an egg is not released from the ovaries during your menstrual
cycle, it cannot become fertilized by sperm and result In pregnancy. DEPO-PROVERA also
causes changes in the lining of your uterus that make it less likely for pregnancy to occur.
HOW EFFECTIVE IS DEPO-PROVERA CONTRACEPTIVE INJECTION?
DEPO-PROVERA is over 99% effective, making it one of the most reliable methods of birth
control available. This means that the average annual pregnancy rate is less than one for
every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive
methods depends in part on how reliably each woman uses the method. The effectiveness
of DEPO-PROVERA depends only on the patient returning every 3 months for her next
injection. Your health-care provider will help you compare DEPO-PROVERA with other con
traceptive methods and give you the information you need in order to decide which contra
ceptive method is the right choice for you.
The following table shows the percent of women who got pregnant while using different
kinds of contraceptive methods. It gives both the lowest expected rate of pregancy (the
rate expected in women who use each method exactly as it should be used) and the typical
rate of pregnancy (which includes women who became pregnant because they forgot to
use their birth control or because they did not follow the directions exactly).
PERCENT OF WOMEN EXPERIENCING AN ACCIDENTAL PREGNANCY
IN THE FIRST YEAR OF CONTINUOUS USE
Method
Lowest
Expected
Typical
DEPO-PROVERA
0.3
0.3
Implants (Norplant®)
0.3
0.3
Female sterilization
0.2
0.4
Male sterilization
0.1
0.15
Oral contraceptive (pill)
V
3
Combined
0.1
Progestogen only
0.5
-
IUD
3
Proqestasert
2.0
Copper T 380A
0.8
-
Condom (without spermicide)
2
12
Diaphragm (with spermicide)
6
18
Cervical Cap
6
18
Withdrawal
4
18
Periodic abstinence
1 - 9
20
Spermicide alone
3
21
Vaginal Sponge
Used before childbirth
6
18
Used after childbirth
9
28
No method
85
85
Source: Trussell et al; Obstet Gyncol 76:558, 1990
WHO SHOULD NOT USE DEPO-PROVERA CONTRACEPTIVE INJECTION?
Not all women should use DEPO-PROVERA. You should not use DEPO-PROVERA if you
think you might be pregnant, have any vaginal bleeding without a known reason, have
had cancer of the breast, have had a stroke, have or have had blood clots (phlebitis) in
your legs, have problems with your liver or liver disease, or are allergic to DEPO-
PROVERA (medroxyprogesterone acetate or any of its other ingredients). You will have a
physical examination before your doctor prescribes DEPO-PROVERA. It is important to
tell your doctor if you are taking any prescription or over-the-counter medications or if
you have a'family history of breast cancer; an abnormal mammogram (breast x-ray),
fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples; kidney
disease; irregular or scanty menstrual periods; high blood pressure; migraine headaches;
asthma; epilepsy (convulsions or seizures); diabetes or a family history of diabetes; or a
history of depression.
WHAT IF I WANT TO BECOME PREGNANT AFTER USING DEPO-PROVERA
CONTRACEPTIVE INJECTION?
Because DEPO-PROVERA is a long-acting birth control method, it takes some time after
your last injection for its effect to wear off. Based on the results from a large study done in
the United States, for women who stop using DEPO-PROVERA in order to become preg
nant, it is expected that about half of those who become pregnant will do so in about 10
months after their last injection; about two thirds of those who become pregnant will do so
in about 12 months; about 83% of those who become pregnant will do so in about 15
months; and about 93% of those who become pregnant will do so in about 18 months after
their last injection. The length of time you use DEPO-PROVERA has no effect on how long
it takes you to become pregnant after you stop using it.
WHAT ARE THE RISKS OF USING DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Irregular Menstrua! Bleeding
The side effect reported most frequently by women who use DEPO-PROVERA for contra
ception is a change in their normal menstrual cycle. During the first year of using DEPO-
PROVERA, you might have one or more of the following changes: Irregular or unpredictable
bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all.
Unusually heavy or continuous bleeding, however, is not a usual effect of DEPO-PROVERA,
and if this happens, you should see your health-care provider right away. With continued
use of DEPO-PROVERA, bleeding usually decreases, and many women stop having peri
ods completely. In clinical studies of DEPO-PROVERA, 57% of the women studied report
ed no menstrual bleeding (amenorrhea) after 1 year of use, and 68% of the women studied
reported no menstrual bleeding after 2 years of use. The reason that your periods stop is
because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not
release an egg monthly, the regular monthly growth of the lining of your uterus does not
occur and, therefore, the bleeding that comes with your normal menstruation does not take
place. When you stop using DEPO-PROVERA your menstrual period will usually, in time,
return to its normal cycle.
2. Bone Mineral Changes
Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral
stored in your bones. This could increase your risk of developing bone fractures. The rate
of bone mineral loss is greatest In the early years of DEPO-PROVERA use, but after that, it
begins to resemble the normal rate of age-related bone mineral loss.
3. Cancer
Studies of women who have used different forms of contraception found that women who
used DEPO-PROVERA for contraception had no increased overall risk of developing cancer
of the breast, ovaiy, uterus, cervix, or liver. However, women under 35 years of age whose
first exposure to DEPO-PROVERA was within the previous 4 years may have a slightly
increased risk of developing breast cancer similar to that seen with oral contraceptives.
You should discuss this with your health-care provider.
4. Accidental Pregnancy
Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental
pregnancy for women who get their shots regularly (every 3 months) is very low. While there
have been reports of an increased risk of low birth weight and neonatal infant death or
other health problems in infants conceived close to the time of injection, such pregnancies
are rare. If you think you may have become pregnant while using DEPO-PROVERA for con
traception, see your health-care provider as soon as possible.
5. Other Risks
Women who use hormone-based contraceptives may have an increased risk of blood clots
or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg
will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare,
you should tell your health-care provider if you have any of the problems listed in the next
section.
WHAT SYMPTOMS MAY SIGNAL PROBLEMS WHILE USING DEPO-PROVERA
CONTRACEPTIVE INJECTION?
Call your health-care provider immediately if any of these problems occur following an
injection of DEPO-PROVERA: Sharp chest pain, coughing of blood, or sudden shortness of
breath (indicating a possible clot in the lung); sudden severe headache or vomiting, dizzi
ness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm
or leg (indicating a possible stroke); severe pain or swelling in the calf (indicating a possible
clot in the leg); unusually heavy vaginal bleeding; severe pain or tenderness in the lower
abdominal area; or persistent pain, pus, or bleeding at the injection site.
WHAT ARE THE POSSIBLE SIDE EFFECTS OF DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Weight Gain
You may experience a weight gain while you are using DEPO-PROVERA. About two thirds
of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5
pounds during the first year of use. You may continue to gain weight after the first year.
Women in one large study who used DEPO-PROVERA for 2 years gained an average total
of 8.1 pounds over those 2 years, or approximately 4 pounds per year. Women who contin
ued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximate
ly 3.5 pounds per year. Women who continued for 6 years gained an average total of 16.5
pounds over those 6 years, or approximately 2.75 pounds per year.
2. Other Side Effects
In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some
women reported the following effects that may or may not have been related to their use of
DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness,
abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps,
nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelling of
the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or
excessive hair loss, rash, and hot flashes. Other problems were reported by very few of the
women in the clinical trials, but some of these could be serious. These include convulsions,
jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of
return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical can
cer. If these or any other problems occur during your use of DEPO-PROVERA, discuss
them with your health-care provider.
SHOULD ANY PRECAUTIONS BE FOLLOWED DURING USE OF DEPO-PROVERA
CONTRACEPTIVE INJECTION?
1. Missed Periods
During the time you are using DEPO-PROVERA for contraception, you may skip a period,
or your periods may stop completely. If you have been receiving your DEPO-PROVERA
injections regularly every 3 months, then you are probably not pregnant. However, if you
think that you may be pregnant, see your health-care provider.
2. Laboratory Test Interactions
If you are scheduled for any laboratory tests, tell your health-care provider that you are
using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones
such as DEPO-PROVERA.
3. Drug Interactions
Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the
effectiveness of DEPO-PROVERA if the two drugs are given during the same time.
4. Nursing Mothers
Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harm
ful effects have been found in these children. DEPO-PROVERA does not prevent the
breasts from producing milk, so it can be used by nursing mothers. However, to minimize
the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth,
you should wait until 6 weeks after childbirth before you start using DEPO-PROVERA for
contraception.
HOW OFTEN DO I GET MY SHOT OF DEPO-PROVERA CONTRACEPTIVE INJECTION?
The recommended dose of DEPO-PROVERA is 150 mg every 3 months given in a single
intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant
at the time of the first injection, it is important that the injection be given only during the first
5 days after the beginning of a normal menstrual period. If used following the delivery of a
child, the first injection of DEPO-PROVERA should be given within 5 days after childbirth if
you are not breast-feeding or 6 weeks after childbirth if you are breast-feeding. If you wait
longer than 3 months between injections, or longer than 6 weeks after childbirth, your
health-care provider should determine that you are not pregnant before giving you your
injection of DEPO-PROVERA.
Caution: Federal law prohibits dispensing without a prescription. You must see a doctor to
receive a prescription.
Upjohn
The Upjohn Company
Kalamazoo, Ml 49001, USA CB-2-S USJ 9529.00
<5